Nestle said on Thursday it was offering $34.50 per share for the remaining 74.4% in peanut allergy treatment maker Aimmune Therapeutics it does not already own, adding a potential blockbuster to its health science portfolio.
FILE PHOTO: A logo is pictured on the Nestle research center before the presentation of Sensationnal Vuna, a plant-based tuna product made by Garden Gourmet, at Vers-chez-les-Blanc in Lausanne, Switzerland August 20, 2020.
REUTERS/Denis Balibouse/File PhotoUnited States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Reliance to buy Future Group's retail arm for $3.38 billionMukesh Ambani-led Reliance Industries said on Saturday it has agreed to acquire the retail and wholesale business and the logistics and warehousing business of Future Group in a deal valued at $3.38 billion, including debt.
Read more »
The Best Leggings That Won’t Pill, Stretch Or Fade, Even If You Wear Them Every Single DayThe best leggings that won’t pill, stretch or fade, even if you wear them every single day.
Read more »
Jennifer Lopez and Alex Rodriguez Are No Longer Buying the NY MetsJennifer Lopez is 'disappointed' she and Alex Rodriguez are no longer buying the New York Mets.
Read more »
Asian airlines are selling in-flight meals directly to the publicAirlines are selling plane food directly to “people who miss flying”, in order to shift surplus
Read more »
Where to Buy a Brompton Bike in LondonThe coronavirus pandemic and lockdown has brought about a cycling boom in the UK, with record numbers of us jumping
Read more »